NANOPARTICLE FORMULATION OF GENTAMISIN IN CHITOSAN-ACEMANNAN CONJUGATE

Staphylococcus aureus (SA) can cause both extracellular and intracellular infections. Gentamicin is an active antibiotic against SA extracellular infection, but its activity is poor against intracellular infections. Chitosan has been used as a carrier in intracellular drug delivery systems. This res...

Full description

Saved in:
Bibliographic Details
Main Author: Saputra Yasir, Angga
Format: Theses
Language:Indonesia
Subjects:
Online Access:https://digilib.itb.ac.id/gdl/view/32356
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:32356
spelling id-itb.:323562018-12-18T10:52:37ZNANOPARTICLE FORMULATION OF GENTAMISIN IN CHITOSAN-ACEMANNAN CONJUGATE Saputra Yasir, Angga Farmakologi dan terapeutik Indonesia Theses Gentamicin, Staphylococcus aureus, Nanoparticle, Chitosan, Acemannan. INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/32356 Staphylococcus aureus (SA) can cause both extracellular and intracellular infections. Gentamicin is an active antibiotic against SA extracellular infection, but its activity is poor against intracellular infections. Chitosan has been used as a carrier in intracellular drug delivery systems. This research aims to formulate gentamicin to resemble SA surface properties. Chitosan conjugate (Chi-Ace) is performed to improve the efficiency and efficacy of gentamicin. The conjugate reactions were carried out by dissolving chitosan with acemannan in acetic acid and then adding Sodium Borohydride (NaBH4) to reduce the chitosan amine bond on the acetyloxy group in acemannan. The production of Chi-Ace nanoparticles was performed by ionotropic gelation method using sodium tripolyphosphate (STPP). The acid acetate solution of Chi-Ace conjugate is mixed with gentamicin solution then crosslink with STPP. The optimization of the formula was performed using a response surface methodology consisting of ¼ factorial to identify significant factors and continued optimization with Box-Behnken design. The prediction of optimum formula consisted of: 10 mg of chitosan; STPP: Chitosan (0.28); 4.1 mg of gentamicin; sonication time 25 seconds and incubation time 30 minutes. The result of the confirmation of the formula shows the particle diameter, the efficiency entrapment and drug loading respectively 320 ± 22 nm; 51 ± 5%; 11.3 ± 0.88% . The release rate of gentamicin from the nanoparticle system at pH 5.2 is higher than at pH 7.4. Gentamicin solution and encapsulated gentamicin in nanoparticles is equal in minimum inhibitory concentration (16 ppm) and minimum bactericidal concentration (32 ppm). text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
topic Farmakologi dan terapeutik
spellingShingle Farmakologi dan terapeutik
Saputra Yasir, Angga
NANOPARTICLE FORMULATION OF GENTAMISIN IN CHITOSAN-ACEMANNAN CONJUGATE
description Staphylococcus aureus (SA) can cause both extracellular and intracellular infections. Gentamicin is an active antibiotic against SA extracellular infection, but its activity is poor against intracellular infections. Chitosan has been used as a carrier in intracellular drug delivery systems. This research aims to formulate gentamicin to resemble SA surface properties. Chitosan conjugate (Chi-Ace) is performed to improve the efficiency and efficacy of gentamicin. The conjugate reactions were carried out by dissolving chitosan with acemannan in acetic acid and then adding Sodium Borohydride (NaBH4) to reduce the chitosan amine bond on the acetyloxy group in acemannan. The production of Chi-Ace nanoparticles was performed by ionotropic gelation method using sodium tripolyphosphate (STPP). The acid acetate solution of Chi-Ace conjugate is mixed with gentamicin solution then crosslink with STPP. The optimization of the formula was performed using a response surface methodology consisting of ¼ factorial to identify significant factors and continued optimization with Box-Behnken design. The prediction of optimum formula consisted of: 10 mg of chitosan; STPP: Chitosan (0.28); 4.1 mg of gentamicin; sonication time 25 seconds and incubation time 30 minutes. The result of the confirmation of the formula shows the particle diameter, the efficiency entrapment and drug loading respectively 320 ± 22 nm; 51 ± 5%; 11.3 ± 0.88% . The release rate of gentamicin from the nanoparticle system at pH 5.2 is higher than at pH 7.4. Gentamicin solution and encapsulated gentamicin in nanoparticles is equal in minimum inhibitory concentration (16 ppm) and minimum bactericidal concentration (32 ppm).
format Theses
author Saputra Yasir, Angga
author_facet Saputra Yasir, Angga
author_sort Saputra Yasir, Angga
title NANOPARTICLE FORMULATION OF GENTAMISIN IN CHITOSAN-ACEMANNAN CONJUGATE
title_short NANOPARTICLE FORMULATION OF GENTAMISIN IN CHITOSAN-ACEMANNAN CONJUGATE
title_full NANOPARTICLE FORMULATION OF GENTAMISIN IN CHITOSAN-ACEMANNAN CONJUGATE
title_fullStr NANOPARTICLE FORMULATION OF GENTAMISIN IN CHITOSAN-ACEMANNAN CONJUGATE
title_full_unstemmed NANOPARTICLE FORMULATION OF GENTAMISIN IN CHITOSAN-ACEMANNAN CONJUGATE
title_sort nanoparticle formulation of gentamisin in chitosan-acemannan conjugate
url https://digilib.itb.ac.id/gdl/view/32356
_version_ 1822923865980928000